Educational Activities

Certified Activity
Non-certified Activity
Resource
Patient Education
Expired Activity

109-114 of 318 Activities

Title
Availability
Format
Credits
Launch Date
Buttons
Buttons
On-Demand
Patient Education
0.00 Resources
03/29/2023
Buttons
On-Demand
Webinar
0.5
03/27/2023

Diagnosing EGPA: Recognizing Signs and Symptoms of the Disease

During this 30-minute CMEO Snack, Drs. Wechsler and Dua will identify best practices and current guidelines for the clinical evaluation and differential diagnosis of EGPA. Using a case presentation to frame the discussion, faculty will explain the differential diagnosis of EGPA as well as how to integrate diagnostic methods and interpret results.

0.5
03/27/2023

Anisha B. Dua

Anisha B. Dua MD, MPH is an Associate Professor of Medicine in the Division of Rheumatology, Rheumatology Fellowship Program Director, and Director of the Northwestern Vasculitis Center at Northwestern University Feinberg School of Medicine.

Anisha B. Dua

Anisha B. Dua MD, MPH is an Associate Professor of Medicine in the Division of Rheumatology, Rheumatology Fellowship Program Director, and Director of the Northwestern Vasculitis Center at Northwestern University Feinberg School of Medicine.

Dr. Dua’s interests are in rheumatology education and vasculitis. She completed her Rheumatology fellowship at Rush University as well as fellowships in Medical Education at The University of Chicago and Integrative Medicine at Northwestern.

Dr. Dua currently leads a multidisciplinary team in the clinical management of vasculitis patients. She assisted in the development of the American College of Rheumatology (ACR) Guideline for the Treatment and Management of Vasculitis, is on the Board of Directors for the Vasculitis Foundation, and a member of the Scientific Advisory Council for the Rheumatology Research Foundation. She is the chair of the e-learning Subcommittee and co-chair of the Workforce Solutions Committee, Virtual Training Programs for the ACR. She has served in leadership capacities both locally and nationally through the American College of Rheumatology, the Vasculitis Foundation, and the ACGME in the areas of education as well as vasculitis. You can follow her on twitter @anisha_dua

Michael E. Wechsler

Michael E. Wechsler is Professor of Medicine in the Division of Pulmonary, Critical Care and Sleep Medicine at National Jewish Health (NJH) in Denver, Director of the NJH/Cohen Family Asthma Institute, and Associate Vice President for Innovation and Industry Relations at NJH.

Michael E. Wechsler

Michael E. Wechsler is Professor of Medicine in the Division of Pulmonary, Critical Care and Sleep Medicine at National Jewish Health (NJH) in Denver, Director of the NJH/Cohen Family Asthma Institute, and Associate Vice President for Innovation and Industry Relations at NJH. In addition to clinical work in pulmonary and critical care medicine, Professor Wechsler’s research focuses on clinical and translational asthma with emphasis on clinical trials in asthma, novel asthma therapies, bronchial thermoplasty, asthma pharmacogenomics, and management of eosinophilic granulomatosis with polyangiitis (i.e. Churg-Strauss Syndrome). He has led studies focusing on novel biologic agents for asthma and related diseases, including benralizumab, dupilumab, mepolizumab, reslizumab, and tezepelumab. He has published more than 270 peer-reviewed manuscripts relating to asthma, EGPA, and eosinophilic lung diseases. He was a member of the Steering Committee and site Principal Investigator (PI) of the NIH-sponsored Asthma Clinical Research Network (ACRN, now called AsthmaNet), a multicenter asthma clinical trials consortium, and currently serves as the PI of the Denver site of the Precision Intervention in Severe/Exacerbating Asthma (PRECISE) network. A member of the American Society of Clinical Investigation and the Association of American Physicians, he has participated in many different task forces related to the study of eosinophilic lung diseases that were sponsored by the NIH, the FDA, the European Respiratory Society, and the International Eosinophil Society. He is currently Associate Editor of the journal Chest and has served as Associate Editor of the journal Allergy and on the editorial board of the European Journal of Clinical Investigation.

Dr. Wechsler received AB and MMSc degrees from Harvard University in Boston and an MD degree from McGill University in Montreal. He completed medical training at Beth Israel Hospital in Boston, and as part of the Harvard Combined Pulmonary and Critical Care Fellowship Training Program.</br.

Buttons
On-Demand
Webinar
1.0
03/23/2023

Educating Frontline Clinicians to Reduce Missed Opportunities for HBV Screening

In this recorded CME Outfitters webcast, expert faculty focus on universal HBV screening with triple panel testing to accurately identify patients with active HBV infection. The faculty also present strategies and best practices for linking patients with HBV to appropriate medical care based on interpretation of serological test results while factoring in SDoH.

1.0
03/23/2023

Chelsey Smith

Chelsey Smith, FNP-C, is a certified Family Nurse Practitioner. She originally attended Shadyside School of Nursing in Pittsburgh, PA, where she received her RN. Chelsey then pursued her interest in nursing, graduating with honors, from Chatham University with a Bachelor of Science in Nursing.

Chelsey Smith

Chelsey Smith, FNP-C, is a certified Family Nurse Practitioner. She originally attended Shadyside School of Nursing in Pittsburgh, PA, where she received her RN. Chelsey then pursued her interest in nursing, graduating with honors, from Chatham University with a Bachelor of Science in Nursing. While working in the neuroscience intensive care unit stepdown in Pittsburgh and providing pediatric home health care, she completed her Master of Science in Nursing with a specialty in Family. Chelsey is a board-certified Family Nurse Practitioner through AANP and licensed in Pennsylvania. She has worked primarily in a retail health care setting as a nurse practitioner since 2013. She has a passion for community health and for care across the lifespan. When not in the clinic, Chelsey enjoys spending time with her husband and two boys (age 10 and 13), gardening, and traveling.

Alyssa Gallipani

Dr. Alyssa Gallipani, PharmD, BCACP, is clinical assistant faculty at Fairleigh Dickinson University. She practices as a clinical ambulatory care pharmacist at RWJBarnabas Health.

Alyssa Gallipani

Dr. Alyssa Gallipani, PharmD, BCACP, is clinical assistant faculty at Fairleigh Dickinson University. She practices as a clinical ambulatory care pharmacist at RWJBarnabas Health. She is a board-certified ambulatory care pharmacist through the Board of Pharmacy Specialties and completed ambulatory care residency training at the Brooklyn Hospital Center. Dr. Gallipani provides direct patient care in collaboration with primary care providers at Barnabas Health Medical Group. She treats chronic disease states, including viral hepatitis, and works to improve access to and affordability of medications and to reduce the cost of care. She had the pleasure of collaborating with the Center for Asian Health to screen and treat individuals with viral hepatitis and participate in community outreach and clinical care initiatives. She presented at multiple viral hepatitis organizations, including the Hepatitis B Foundation and the Hepatitis B United Summit. Dr. Gallipani precepts advanced pharmacy practice experience (APPE) students and residents to advocate for the role of the pharmacist as future providers. She is honored to be a part of the panel today with other leaders and trail blazers in the profession.

Su H. Wang

Su Wang, MD, MPH, FACP is the Medical Director of Viral Hepatitis Programs and the Center for Asian Health at Cooperman Barnabas Medical Center and Past President of the World Hepatitis Alliance, a non-governmental organization (NGO) committed to viral hepatitis elimination.

Su H. Wang

Su Wang, MD, MPH, FACP is the Medical Director of Viral Hepatitis Programs and the Center for Asian Health at Cooperman Barnabas Medical Center and a member of the RWJBarnabas Health Medical Group. She is Past President of the World Hepatitis Alliance, a non-governmental organization (NGO) committed to viral hepatitis elimination.

Dr. Wang is an internist and has served as primary investigator for a number of viral hepatitis screening and linkage-to-care grants sponsored by the U.S. Centers for Disease Control and Prevention (CDC) and other funders. She has led primary care-based hepatitis B and C programs, community outreach efforts, patient-based advocacy, and community-based research initiatives.

Dr. Wang has served on a number of World Health Organization (WHO) guideline development committees producing “Prevention of Mother-to-Child Transmission of Hepatitis B Virus: Guidelines on Antiviral Prophylaxis in Pregnancy” and “Interim Guidance for Country Validation of Viral Hepatitis Elimination.” She is a member of the American Association for the Study of Liver Diseases (AASLD) and serves on the steering committee for the HBV Special Interest Group and the Viral Hepatitis Elimination Taskforce, and is on the Patient Advisory Group.

She received her medical degree from the University of Miami and her Masters of Public Health from Johns Hopkins School of Public Health. Dr. Wang completed a combined Internal Medicine and Pediatric residency at Georgetown University Hospital and then served as an Epidemic Intelligence Service officer for the CDC at the U.S. Food and Drug Administration (FDA). She was previously the Director of Hepatitis Programs at the Charles B. Wang Community Health Center in New York City.

Buttons
On-Demand
Podcast
0.75
03/22/2023

Health Inequities in Mental Health Care

In this CME Outfitters podcast episode, expert faculty will discuss cultural and systemic challenges faced by ethnic/racially diverse patients, and empower health care professionals with education, tools, and resources to address these challenges and provide more equitable mental health care for all.

0.75
03/22/2023

Jessica Isom

Jessica Isom, MD, MPH, is a board-certified community psychiatrist and faculty leader in the Yale Department of Psychiatry’s Social Justice and Health Equity Curriculum

Jessica Isom

Jessica Isom, MD, MPH, is a board-certified community psychiatrist and faculty leader in the Yale Department of Psychiatry’s Social Justice and Health Equity Curriculum. She primarily works in Boston as an attending psychiatrist at Codman Square Health Center where she is leading a grant effort to infuse antiracism in OUD services. She is a nationally recognized expert on racial equity and justice in psychiatry with a focus on workforce development and organizational transformation. Her professional interests include working toward eradicating racial and ethnic mental health disparities, mitigating the impact of implicit racial bias on clinical care, and the use of a community-centered population health approach in psychiatric practice. She serves on multiple advisory boards and is a consultant, curriculum developer, and presenter to a variety of organizations including Fortune 500 companies and medical societies through her company, Vision for Equity LLC.

Amanda J. Calhoun

Dr. Calhoun’s research, which focuses on the mental health effects of anti-Black racism on children, has been funded by multiple national awards. Dr. Calhoun also specializes in the effects of medical racism and writes for both academic journals as well as general press and has published in New England Journal of Medicine, TIME magazine, HuffPost, STAT News, Washington Post, BET News, and many others.

Amanda J. Calhoun

Amanda J. Calhoun, MD, MPH, is an Adult/Child Psychiatry Resident at Yale Child Study Center/Yale School of Medicine and is concurrently pursuing a PhD in Yale’s Graduate School of Arts & Sciences.  Dr. Calhoun graduated from Yale University with a BA in Spanish and received her MD/MPH from Saint Louis University School of Medicine, in St. Louis, Missouri, where she grew up.  Dr. Calhoun’s research, which focuses on the mental health effects of anti-Black racism on children, has been funded by multiple national awards.  Dr. Calhoun also specializes in the effects of medical racism and writes for both academic journals as well as general press and has published in New England Journal of Medicine, TIME magazine, HuffPost, STAT News, Washington Post, BET News, and many others. Dr. Calhoun is also a public speaker, and a consultant and has made multiple national news appearances, most recently on CBS News discussing the rising rates of Black youth suicide.

Twitter handle: @AmandaJoyMD

Professional Instagram: amandajoymd

Monica E. Peek

Monica Peek, MD, MPH, MSc is an Ellen H. Block Professor of Health Justice in the Department of Medicine.

Monica E. Peek

Monica Peek, MD, MPH, MSc is an Ellen H. Block Professor of Health Justice in the Department of Medicine. She is also the Associate Director, Chicago Center for Diabetes Translation Research, and Director of Research, MacLean Center for Clinical Medical Ethics. She is a practicing internist, medical educator, and clinician investigator. Her research pursues health equity and social justice, with a focus on promoting equitable doctor/patient relationships among racial minorities, integrating the medical and social needs of patients, and addressing health care discrimination and structural racism impacting health outcomes (e.g., diabetes, COVID-19). Dr. Peek has authored more than 200 peer-reviewed publications and abstracts on health care disparities, diversity, and bias; has been the principal investigator of multiple grants to address health disparities; and has been invited to speak at numerous local and national medical meetings.

Buttons
On-Demand
Patient Education
0.00 Resource
03/14/2023

How Does Depression Affect You?

Tackling Major Depressive Disorder can feel overwhelming. View this short video animation for guidance on how to get started with depression treatment and find a road to recovery that works for you.

0.00 Resource
03/14/2023
Buttons
On-Demand
Webinar
1.0
03/07/2023

Manifestations of Gaucher Disease: Rare or Under-recognized?

During this 60-minute recorded symposium, expert panelists will discuss GD, including its less commonly reported manifestations, diagnostic pathways, and patient-centric multidisciplinary management of the disorder.

1.0
03/07/2023

Neal J. Weinreb

Neal J. Weinreb, MD, FACP is a graduate of the Jewish Theological Seminary (Bachelor of Hebrew Literature), and SUNY Downstate Health Sciences University (MD, summa cum laude).

Neal J. Weinreb

Neal J. Weinreb, MD, FACP is a graduate of the Jewish Theological Seminary (Bachelor of Hebrew Literature), and SUNY Downstate Health Sciences University (MD, summa cum laude). After a residency in Internal Medicine at Albert Einstein College of Medicine and a fellowship and faculty position at Mt. Sinai School of Medicine, NY, he practiced Hematology and Medical Oncology in South Florida. Dr. Weinreb, the director of the University Research Foundation for Lysosomal Storage Diseases in Boca Raton, FL, retired from clinical practice in May 2018. He now devotes his entire professional attention to clinical research about Gaucher Disease and Fabry Disease. Dr Weinreb is a Voluntary Associate Professor of Human Genetics and Medicine at the University of Miami Miller School of Medicine. Dr. Weinreb is an investigator for the Gaucher and Fabry Registries and a member of the Medical Advisory Board for the National Gaucher Foundation and of the International Working Group for Gaucher Disease.

Coy Heldermon

Dr. Coy Heldermon is an associate professor of medicine and board-certified medical oncologist at the University of Florida with expertise in the treatment of breast cancer.

Coy Heldermon

Dr. Coy Heldermon is an associate professor of medicine and board-certified medical oncologist at the University of Florida with expertise in the treatment of breast cancer. He is a member of the American Society of Hematology and the American Society of Clinical Oncology. His research expertise is in the use of gene replacement and stem cell therapies for the treatment of inherited disorders such as lysosomal storage diseases.

Tamanna Roshan Lal

Dr. Roshan Lal is a Pediatric Clinical and Metabolic Geneticist working at the Rare Disease Institute, Children's National Hospital in Washington DC.

Tamanna Roshan Lal

Dr. Roshan Lal is a Pediatric Clinical and Metabolic Geneticist working at the Rare Disease Institute, Children’s National Hospital in Washington DC. Her clinical and research interests are geared towards improving the quality of life for children with rare genetic diseases, specifically lysosomal storage diseases and neuro-genetic disorders. Her special interest includes being involved in clinical trials using orphan drugs as well as gene therapy. She is currently the Director of Clinical Trials and Director of International Patient Consultations and Care Referrals for the Rare Disease Institute at the Children’s Hospital.